AZD-1419

N/A

Report date: 2023/09/25 20:03:35

NME

Base Information

Drug NameAZD-1419

Drug Alias NameSecond-generation TLR-9 agonist - AstraZeneca/DynavaxAZD-1419AZ-1419

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide

Mechanisms of ActionToll like receptor 9 agonists

TargetsToll like receptor 9

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwedenPolandHungary +[4]

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAstrazeneca Plc

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A